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Abstract Protein tyrosine phosphatase 1C (PTP1C), highly 
expressed in hematopoietic ells, is a soluble protein tyrosine 
phosphatase containing two Src homology 2 (SH2) domains at 
the N-terminns and two putative sites of tyrosine phosphorylation 
at the C-terminus. This paper reports that PTP1C and c-Src 
could be coimmunoprecipitated during thrombin-induced platelet 
activation. Moreover, association between the two signalling 
proteins occurred only after PTP1C had been tyrosine phos- 
phorylated. In in vitro experiments, PTPIC bound to the SH2 
domain of c-Src, suggesting that association between tyrosine 
phosphorylated PTP1C and c-Src was mediated by the SH2 
domain of c-Src. Finally, in resting platelets, PTP1C was mainly 
found in the Nonidet P-40 soluble fraction whereas following 
thrombin-induced activation, around 17% of PTP1C was 
associated with the insoluble fraction. 
ikey words: Protein tyrosine phosphatase 1C; c-Src; 
SH2 domain; Human platelet 
1~ Introduction 
Numerous phosphotyrosine proteins have been detected in 
normal non-proliferative and terminally differentiated cells 
s ach as platelets [1]. Most tyrosine proteins are phosphory- 
lated during platelet activation induced by physiological go- 
nists such as thrombin and collagen [2-4], as well as by thap- 
sgargin [5,6], or the monoclonal antibody P256 directed 
against the integrin C~Hb133, the receptor for fibrinogen also 
named glycoprotein IIb-II Ia [7]. Among the tyrosine phos- 
phorylated proteins described in platelets, some have been 
detected in cellular contact regions and are related to platelet 
aggregation such as the focal adhesion kinase FAK [8]. How- 
ever, most of them have not yet been identified and their roles 
r .,'main unknown. 
Several protein tyrosine kinases (PTKs) have been identified 
ia platelets, c-Src is highly expressed together with some 
~thers of the same family [2,3,9], Other soluble PTKs have 
~lso been identified such as FAK, Syk, a tandem Src homol- 
cgy 2 (SH2) domains kinase [10] and Matk, a Csk-like protein 
[: 1]. Modulation of platelet yrosine kinase activity depends 
~rnong others on intracellular Ca 2+ [6], on activation of pro- 
I fin kinase C, or on activation of the integrin O~iib[~ 3 [12]. 
Phosphorylation at tyrosine residues being the result of a 
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balance between PTK and protein tyrosine phosphatase (PTP) 
activities, some PTPs have also been characterized in human 
platelets. One of these, PTP1C, also named SHPTP1, HCP 
and SHP [13-16], is expressed in many hematopoietic cells, 
and is notably present in platelets [14,17]. It possesses a large 
non-catalytic region at the N-terminus with two adjacent SH2 
domains, suggesting that it may interact with phosphotyrosine 
proteins [18,19]. PTP1C was first described to be phosphory- 
lated on tyrosine in macrophages in response to colony stim- 
ulating factor-1 [20]. Later, two putative sites of tyrosine 
phosphorylation were described at the C-terminus [21,22]. In 
platelets, it is not clearly established whether this phosphatase 
plays a role in an early signalling event or in an aggregation- 
dependent mechanism. Indeed, PTP1C phosphorylation oc- 
curs within the first seconds of stimulation [23,24]. However, 
depending on the reports, this phosphorylation follows plate- 
let aggregation [23] or does not [24]. Moreover, translocation 
of c-Src and PTP1C to the platelet cytoskeleton has been 
described, but up to now there is no evidence of any interac- 
tion between the two molecules. The results presented here 
confirm that PTP1C was rapidly phosphorylated on tyrosine 
in human platelets after stimulation with thrombin, and show 
that this phosphorylation allows PTPIC to bind the SH2 do- 
main of c-Src. The functional implication of this binding is 
discussed. 
2. Materials and methods 
2.1. Antibodies, materials and chemicals 
Polyclonal R278 and monoclonal anti-PTP1C antibodies were from 
Dr. E.R. Stanley (Albert Einstein College of Medicine, New York, 
USA) and from Transduction Laboratories (Affiniti, Mamhead, UK), 
respectively. Polyclonal N-16 and monoclonal GDll anti-Src anti- 
bodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, 
USA) and from UBI (Euromedex, Souffelweyersheim, France), re- 
spectively. Monoclonal anti-phosphotyrosine antibody 4G10 was 
from Dr. B.J. Druker (Oregon Health Science University, Portland, 
USA) [25]. The pGEX vectors which contain glutathione S-transferase 
(GST) or GST-Src SH2 domain fusion protein were obtained from 
Dr. L.C. Cantley (Harvard Medical School, Boston, USA), and GST- 
PTP1C SH2 domains, which associates GST with the two SH2 do- 
mains of PTP1C, from Dr. T. Yi (St Jude Children's Research Hos- 
pital, Memphis, USA). 
All SDS-polyacrylamide g l electrophoresis (SDS-PAGE) reagents 
were from Bio-Rad (Irvy sur Seine, France), and Na3VO4 from Fisher 
Scientific (Fair Lawn, USA). All other chemicals were of the highest 
available purity. 
2.2. Platelet preparation, activation and Western blotting 
Blood from healthy donors was anticoagulated in 0.1 vol. of ACD- 
C. Platelets were isolated from plasma on a metrizamide gradient 
(Eurobio, Les Ulis, France), as previously described [26], resuspended 
in 140 mM NaC1, 3 mM KC1, 0.5 mM MgCI2, 5 mM NaHCO3, 
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10 mM glucose and 10 mM HEPES, pH 7.4, and adjusted to 4x l0 s 
cells/ml. Stimulation was performed on 0.4 ml aliquots in the cuvette 
of an aggregometer at 37°C under constant stirring (1100 rpm) in the 
presence of 1 mM CaCI2. Platelets were stimulated with 0.1 U/ml 
bovine thrombin (Hoffmann La Roche, Basel, Switzerland), and 
then solubilized in sample buffer containing 5% ~-mercaptoethanol 
and boiled for 5 min. Proteins were separated by SDS-PAGE [27] 
before transfer to nitrocellulose membrane. Membranes were incu- 
bated in a blocking solution (100 mM NaC1, 20 mM Tris, pH 7.4) 
containing 5% low fat dry milk before probing with the specific anti- 
body. Detection was performed with an enhanced chemiluminescence 
system (ECL, Amersham, Les Ulis, France). When a second probing 
was required, stripping was performed by washing in 62.5 mM Tris, 
pH 6.8, 0.1 M [3-mercaptoethanol and 2% SDS at 60°C for 30 min. 
Membranes were washed, incubated in the blocking solution and 
probed with a second antibody. 
2.3. Immunoprecipitation andbinding to GST-fusion proteins 
In an attempt o preserve associations between signalling proteins 
during solubilization, we used 1% Nonidet P-40 (NP-40). Platelets 
were lysed by incubation with 0.5 vol. of 3 X lysis buffer (3% NP-40, 
150 mM Tris-HC1, pH 7.4, 450 mM NaCI, 3 mM EGTA, 3 mM 
PMSF, 1.5 mM NaaVO4, 150 mM benzamidine, 15 Ixg/ml eupeptin 
and 15 pg/ml aprotinin) for 30 min at 4°C. The insoluble fraction was 
sedimented by centrifugation at 16000Xg for 10 min. The soluble 
fraction was incubated with the polyclonal anti-PTP1C antibody 
R278 and immune complex precipitated with protein A-Sepharose. 
Expression of GST fusion proteins was induced by the addition of 
1 mM isopropyl-~l-D-thiogalactopyranoside and the fusion proteins 
were produced and purified from bacterial lysates as previously de- 
scribed [28]. The NP-40-soluble fraction of lysed platelets was incu- 
bated with fusion proteins bound to glutathione-Sepharose. In both 
cases, beads were solubilized in a SDS-PAGE sample buffer and pro- 
teins analyzed by Western blotting as described above. 
2.4. ELISA 
Plates were coated overnight with the polyclonal anti-PTP1C anti- 
body R278 and incubated with a blocking solution containing 1% 
bovine serum albumin. Lysates and soluble fractions from 4x107 
platelets were added to the wells and PTP1C probed with monoclonal 
antibody, o-Phenylenediamine was used as substrate and the absor- 
bance read at 490 nm in a multichannel analyser (Dynatech MR 5000, 
Guyancourt, France). PTP1C was measured in platelet lysates and 
soluble fractions, and was expressed in percent of the absorbance in
platelet lysates. 
3. Results 
3.1. Thrombin induces the tyrosine phosphorylation f PTP1C 
and its association with c-Src 
Fig. 1A shows that stimulation of human platelets with 
thrombin induced and increased the tyrosine phosphorylation 
of several proteins, a result consistent with previous reports. 
Among them, a 64 kDa phosphotyrosine protein was identi- 
fied as PTP1C by immunoprecipitation with anti-PTP1C anti- 
body. In resting platelets PTP1C was not phosphorylated on 
tyrosine, nor was it associated with any phosphotyrosine pro- 
tein. After stimulation, PTP1C was tyrosine phosphorylated. 
Tyrosine phosphorylation of PTP1C was also confirmed by 
immunoprecipitation with monoclonal antiphosphotyrosine 
antibody (data not shown). 
After 3 min of activation, a 60 kDa phosphotyrosine pro- 
tein coimmunoprecipitated with PTP1C. The 60 kDa phos- 
photyrosine protein was identified as c-Src by immunoblotting 
with a monoclonal anti-Src antibody (Fig. 1B). This associa- 
tion was observed after 30 s of activation and was more im- 
portant after 1 min. 
3.2. PTPI C binds in vitro the SH2 domain of c-Src 
The interaction of PTP1C with c-Src was investigated using 
GST fusion proteins containing either c-Src or PTP1C SH2 
domains (Fig. 2). In resting platelets the GST-Src SH2 do- 
main associated with a 60 kDa phosphotyrosine protein and 
GST-PTP1C SH2 domains with one of 34 kDa. 
After 3 min of thrombin-induced activation, the GST-Src 
SH2 domain associated with phosphotyrosine proteins of 42, 
56, 60 (identified as c-Src [9]), 64 and 140 kDa. The 64 kDa 
protein was identified by specific immunoblotting as PTP1C. 
The association between PTP1C and the GST-Src SH2 do- 
main was dependent on platelet activation since no associa- 
tion was observed in resting platelets. Under the same activat- 
ing conditions, GST-PTP1C SH2 domains associated with 
unidentified phosphotyrosine proteins of 32, 34 and 38 kDa. 
A weak association of GST-PTP1C SH2 domains with c-Src 
was observed, which was not related to the high degree of c- 
Src tyrosine phosphorylation i the lysate. 
3.3. Translocation of PTP1C to the NP-40 insoluble fraction 
Following stimulation, many signalling proteins from plate- 
lets relocalize from a soluble fraction to an insoluble fraction. 
Fig. 3 shows that the amount of PTP1C in the insoluble 
fraction increased during thrombin-induced activation, sug- 
gesting a relocalization of PTP1C during thrombin-induced 
stimulation. Moreover, relocalization of PTP1C seemed to 
be slower than that of the main phosphotyrosine protein c- 
Src. In resting platelets c-Src was largely soluble and after 
1 min of activation was present in insoluble fraction whereas 
PTP1C appeared only after 3 min. To quantify PTP1C relo- 
calization, we developed an ELISA method and evaluated the 
amount of PTP1C present in soluble fraction (Table 1). By 
this method we estimated that 96% of total PTP1C was pre- 
sent in the soluble fraction of resting platelets compared to 
83% present after 10 min of stimulation with thrombin. Thus, 
17% of the total PTP1C was found in the actin cytoskeleton 
after 10 min of thrombin-induced activation. 
4. Discussion 
In the present report, we showed that PTP1C was phos- 
phorylated on tyrosine after platelet activation [23,24], there- 
by forming a binding site to the c-Src SH2 domain. 
Using immunoprecipitation f PTP1C and immunoblotting 
with an anti-phosphotyrosine antibody, we confirmed the in- 
crease in tyrosine phosphorylation of PTP1C during activa- 
Table 1 
Quantification of the percentage of PTP1C present in the NP-40 soluble fraction 
Time (min) 
0 1 3 5 10 
% of PTP1C in NP-40 soluble fraction 96+3 93+2 90+9 83+4 83+ 1 
Platelets were stimulated for the indicated times as described in Fig. 1. Quantification of PTP1C in soluble fractions of platelet lysates was 
performed by ELISA as described in section 2. Results are expressed in percent of the total amount and are mean + S.E. of duplicate determi- 
nations in four experiments. 
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F g. 1. Thombin induces the tyrosine phosphorylation f PTP1C and its association with c-Src. (A) Platelets were stimulated with 0.1 U/ml 
thrombin for 1 and 3 min at 37°C under constant stirring in the presence of 1 mM CaCI2. (Left) Platelet proteins were resolved by 8% SDS- 
polyacrylamide g l electrophoresis (SDS-PAGE), transferred to nitrocellulose membranes, and immunoblotted (WB) with monoclonal nti-phos- 
pi~otyrosine (pTyr) antibody. (Right) Soluble fraction of platelet lysates were immunoprecipitated (IP) with polyclonal anti-PTP1C antibody. 
Nitrocellulose membrane was immunoblotted with monoclonal anti-phosphotyrosine antibody (upper panel), stripped, and immunoblotted with 
polyclonal anti-PTP1C antibody (lower panel). (B) Platelets were stimulated with 0.1 U/ml thrombin for 0.5 and 1 min at 37°C under constant 
st~rring in the presence of 1 mM CaC12. Soluble fractions of platelet lysate were immunoprecipitated with polyclonal anti-PTP1C antibody. Ni- 
tr.gcellulose membrane was immunoblotted with monoclonal anti-Src antibody. The 55 kDa band is the IgG heavy chain from the antibody 
u,ed for immunoprecipitation. The positions of molecular mass markers are indicated in kDa. 
ti ~n [23,24]. The migration in SDS-PAGE of PTP1C corre- 
sponded to the migration of the prominent tyrosine protein of 
64 kDa [29]. No dephosphorylation f PTP1C was observed 
~ith thrombin, even after 10 min of activation (data not 
shown). This result contrasts with the transient phosphoryla- 
ti~n of PTP1C induced by growth factors in A431 and 293 
ct:lls [22]. 
Regulation of signalling proteins by their phosphorylation 
i,, a general feature. Increase in phosphatase activity upon 
t~rosine phosphorylation has been reported for PTP1C in 
p atelets [24] and for CD45 in T lymphocytes [30,31]. Tyrosine 
pilosphorylation also allows interactions with SH2 domains 
[I 8,19] or phosphotyrosine interaction domains [32,33]. The 
st quences surrounding the two phosphorylation sites of 
P FP1C (Tyr-538 and Tyr-566) are Tyr-Gly-Asn-Ile and Tyr- 
(ilu-Asn-Leu, respectively [22]. These two sequences present 
some homology with the consensus equence for binding to 
t le  Src SH2 domain (pTyr-Glu-Glu/Asn/Tyr-Ile/Met/Leu) 
[34]. Therefore, we examined the possibility that PTP1C could 
b~nd to c-Src during platelet activation. In non-activated 
pIatelets, unphosphorylated PTP1C was not associated with 
phosphorylated c-Src. When platelets were stimulated by 
tl~rombin, a fraction of c-Src was coimmunoprecipitated 
with PTP1C. This association was detectable after 30 s of 
activation, at which time PTP1C was already phosphorylated 
on tyrosine. Through in vitro experiments, tyrosine phos- 
phorylated PTP1C was shown to bind to the GST-Src SH2 
domain. Together, these results uggest that the tyrosine phos- 
phorylation of PTP1C allows its binding to c-Src via the SH2 
domain of c-Src. 
The PTK responsible for the tyrosine phosphorylation of
PTP1C has yet to be identified. Tyr-566 is phosphorylated by
Src in v-Src-transformed rat fibroblasts [35] and Tyr-564 of 
SHPTP1 (corresponding to Tyr-566 of PTP1C) by Lck, a Src 
family PTK, in murine T cells [36]. Beside Src, other soluble 
platelet PTKs of the Src family (Fyn, Lyn, Hck, Yes), or 
Matk, are also potential candidates. Indeed, Matk presents 
some similarity with Csk which phosphorylates CD45 in T 
lymphocytes [30]. Through in vitro experiments it was shown 
that tyrosine phosphorylation f CD45 increases its phospha- 
tase activity and creates a binding site for Lck SH2 domain 
with a higher affinity than its own pTyr-505, leading to de- 
phosphorylation of pTyr-505 and Lck activation. Similarly, 
tyrosine phosphorylated PTP1C might displace c-Src pTyr- 
527 from its SH2 domain, then dephosphorylate pTyr-527 
and thus activate c-Src. Such an activation mechanism, by 
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Fig. 2. The tyrosine phosphorylated PTP1C binds to GST-Src SH2 fusion protein. Platelets were not stimulated (Resting) or stimulated with 
thrombin for 3 min (Thr 3 min) as described in Fig. 1. Soluble fractions of platelet lysate were incubated with 2 }.tg GST fusion proteins immo- 
bilized on glutathione-Sepharose beads. Protein complexes were resolved by 12% SDS-PAGE, transferred to nitrocellulose membranes, and im- 
munoblotted with monoclonal nti-phosphotyrosine a tibody (two left panels) or polyclonal anti-PTP1C antibody (right lane). 
dephosphorylation f an inactive PTK, is now well documen- 
ted. In Fischer rat embryo fibroblasts, overexpression of 
PTPet results in a persistent activation of c-Src by depho- 
sphorylation at pTyr-527, with concomitant cell transforma- 
tion and tumorigenesis [37]. Dephosphorylation f pTyr-527 
of c-Src has also been observed in chicken preB DT40 cells 
overexpressing ChPTP~, [38]. In accordance with this hypoth- 
esis, c-Src pTyr-527 is rapidly dephosphorylated during 
thrombin-induced platelet activation [39]. 
Another feature of PTP1C concerns its translocation during 
activation. In control platelets, PTP1C was mainly found in 
NP-40 insoluble 
0 1 3 
WB otPTP 1C 
WB o~Src 
Fig. 3. PTP1C relocalizes in the NP-40 insoluble fraction during 
thrombin-induced activation. Platelets were stimulated for the indi- 
cated times as described in Fig. 1. Insoluble fractions were resolved 
by 8% SDS-PAGE, transferred to nitrocellulose membranes, and 
immunoblotted with monoclonal anti-PTP1C (upper) or polyclonal 
anti-Src (lower) antibodies. 
the soluble fraction after NP-40 solubilization. Following 
thrombin activation, PTP1C was partially located in the in- 
soluble fraction, as previously described [17]. The ELISA as- 
say we have developed allowed an estimation of 4% of the 
total amount of PTP1C in the actin cytoskeleton of resting 
platelets, whereas 17% was found in this insoluble fraction 
after 10 min of thrombin-induced activation. 
In conclusion, PTP1C appears to be implied both during 
initial times (early phosphorylation) and in later steps of 
platelet activation. Tyrosine phosphorylation, which increases 
PTP1C phosphatase activity [24], could allow its binding to 
the SH2 domain of c-Src. Thus, c-Src could be a potential 
substrate for PTP1C becoming activated by dephosphoryla- 
tion of pTyr-527. 
Acknowledgements. Weare grateful to Dr. E.R. Stanley for providing 
the polyclonal anti-PTP1C antibody R278, Dr. T. Yi and Dr. L.C. 
Cantley for GST fusion proteins, and Dr. B.J. Druker for the mono- 
clonal anti-phosphotyrosine a tibody 4G10. We thank S. Crick for 
stylistic revision. H.F. is a recipient of an award from the Minist~re de 
l'Enseignement suprrieur et de la Recherche. F.R.-M. was supported 
by a fellowship from the Spanish Ministerio de Educaci6n y Ciencia 
and an EEC postdoctoral fellowship (Human Capital and Mobility 
program). This work was supported by Dret Grant 93/077 (F.R.). 
References 
[1] Tuy, F.P.D., Henry, J., Rosenfeld, C. and Kahn, A. (1983) Nat- 
ure 305, 435-438. 
H Falet et al./FEBS Letters 383 (1996) 165-169 169 
[2] Ferrel, J.E., Jr. and Martin, G.S. (1988) Mol. Cell. Biol. 8, 3603- 
3610. 
[3] Golden, A. and Brugge, J.S (1989) Proc. Natl. Acad. Sci, USA 
86, 901-905. 
[4] Nakamura, S. and Yamamura, H. (1989) J. Biol. Chem. 264, 
7089-7091. 
[5] Vostal, J.G., Jackson, W.L. and Shulman, N.R. (1991) J. Biol. 
Chem. 266, 16911-16916. 
[tq Falet, H. and Rendu, F. (1994) FEBS Lett. 345, 87-91. 
[7] Bachelot, C., Sulpice, J.-C., Giraud, F. and Rendu, F. (1991) 
Cell. Signalling 3, 537-546. 
['] Lipfert, L., Haimovich, B., Schaller, M.D., Cobb, B.S., Parsons, 
J.T. and Brugge, J.S. (1992) J. Cell. Biol. 119, 905-912. 
[~] Rendu, F., Lebret, M., Danielian, S., Fagard, R., L6vy-Toleda- 
no, S. and Fischer, S. (1989) Blood 73, 1545-1551. 
[1~] Taniguchi, T., Kitagawa, H., Yasue, S., Yanagi, S., Sakai, K., 
Asahi, M., Ohta, S., Takeuchi, F., Nakamura, S. and Yama- 
mura, H. (1993) J. Biol. Chem. 268, 2277-2279. 
[1 i] Bennett, B.D., Cowley, S., Jiang, S., London, R., Deng, B., Gra- 
barek, J., Groopman, J.E., Goeddel, D.V. and Avraham, H. 
(1994) J. Biol. Chem. 269, 1068-1074. 
[1. ~] Clark, E.A., Shattil, S.J. and Brugge, J.S. (1994) Trends Bio- 
chem. Sci. 19, 464-469. 
[1 :] Shen, S.-H., Bastien, L., Posner, B.I. and Chr6tien, P. (1991) 
Nature 352, 736-739. 
[lz] Plutzky, J., Neel, B.G. and Rosenberg, R.D. (1992) Proc. Natl. 
Acad. Sci. USA 89, 1123 1127. 
[1:1 Yi, T., Cleveland, J.L. and Ihle, J.N. (1992) Mol. Cell. Biol. 12, 
836-846. 
[It.] Matthews, R.J., Bowne, D.B., Flores, E. and Thomas, M.L. 
(1992) Mol. Cell. Biol. 12, 2396-2405. 
[1"1 Li, R.Y., Gaits, F., Ragab, A., Ragab-Thomas, J.M.F. and 
Chap, H. (1994) FEBS Lett. 343, 89-93. 
[11, I Anderson, D., Koch, C.A., Grey, L., Ellis, C., Moran, M.F. and 
Pawson, T. (1990) Science 250, 979-982. 
[191 Koch, C.A., Anderson, D., Moran, M.F., Ellis, C. and Pawson, 
T. (1991) Science 252, 668-674. 
[21 I Yeung, Y.-G., Berg, K.L., Pixley, F.J., Angeletti, R.H. and Stan- 
ley, E.R. (1992) J. Biol. Chem. 267, 23447-23450. 
[21[ Uchida, T., Matozaki, T., Noguchi, T., Yamao, T., Horita, K., 
Suzuki, T., Fujioka, Y., Sakamoto, C. and Kasuga, M. (1994) 
J. Biol. Chem. 269, 12220-12228. 
[22] Bouchard, P., Zhao, Z., Banville, D., Dumas, F., Fischer, E.H. 
and Shen, S.-H. (1994) J. Biol. Chem. 269, 19585-19589. 
[23] Ezumi, Y., Takayama, H. and Okuma, M. (1995) J. Biol. Chem. 
270, 11927-11934. 
[24] Li, R.Y., Gaits, F., Ragab, A., Ragab-Thomas, J.M.F. and 
Chap, H. (1995) EMBO J. 14, 2519-2526. 
[25] Druker, B.J., Mamon, H.J. and Roberts, T.M. (1989) N. Engl. J. 
Med. 321, 1383-1391. 
[26] Bachelot, C., Saffroy, R., Gandrille, S., Aiach, M. and Rendu, F. 
(1995) Thromb. Haemostas. 74, 1557-1563. 
[27] Laemmli, U.K. (1970) Nature 227, 680-685. 
[28] Ramos-Morales, F., Druker, B.J. and Fischer, S. (1994) Onco- 
gene 9, 1917-1923. 
[29] Bachelot, C., Cano, E., Grelac, F., Saleun, S., Druker, B.J., 
L6vy-Toledano, S., Fischer, S. and Rendu, F. (1992) Biochem. 
J. 284, 923-928. 
[30] Autero, M., Saharinen, J., Pessa-Morikawa, T., Soula-Rothhut, 
M., Oetken, C., Gassmann, M., Bergman, M., Alitalo, K., Burn, 
P., Gahmberg, C.G. and Mustelin, T. (1994) Mol. Cell. Biol. 14, 
1308-1321. 
[31] Stover, D.R. and Walsh, K.A. (1994) Mol. Cell. Biol. 14, 5523- 
5532. 
[32] Kavanaugh, W.M. and Williams, L.T. (1994) Science 266, 1862- 
1865. 
[33] Bork, P. and Margolis, B. (1995) Cell 80, 693-694. 
[34] Songyang, Z., Shoelson, S.E., Chaudhuri, M., Gish, G., Pawson, 
T., Haser, W.G., King, F., Roberts, T., Ratnofsky, S., Lechlei- 
der, R.J., Neel, B.G., Birge, R.B., Fajardo, J.E., Chou, M.M., 
Hanafusa, H., Schaffhausen, B. and Cantley, L.C. (1993) Cell 72, 
767 778. 
[35] Matozaki, T., Uchida, T,, Fujioka, Y. and Kasuga, M. (1994) 
Biochem. Biophys. Res. Commun. 204, 874 881. 
[36] Lorenz, U., Ravichandran, K.S., Pei, D., Walsh, C.T., Burakoff, 
S.J. and Neel, B.G. (1994) Mol. Cell. Biol. 14, 1824-1834. 
[37] Zheng, X.M., Wang, Y. and Pallen, C.J. (1992) Nature 359, 336- 
339. 
[38] Fang, K.S., Sabe, H., Saito, H. and Hanafusa, H. (1994) J. Biol. 
Chem. 269, 20194-20200. 
[39] Clark, E.A. and Brugge, J.S. (1993) Mol. Cell. Biol. 13, 1863- 
1871. 
